Why the study?
Does a single oral dose of felodipine improve central and renal hemodynamics in patients with refractory hypertension?
Does a single oral dose of felodipine improve central and renal hemodynamics in patients with refractory hypertension?
A single oral dose of felodipine effectively reduces blood pressure while increasing cardiac output and renal plasma flow in patients with refractory hypertension.
Answers are grounded in this paper and cite their sources.
Acute felodipine effects in refractory hypertension should not yet change practice; leaves open durability and outcomes in randomized trials.
In 12 patients with primary hypertension (World Health Organization stage 2) inadequately controlled by chronic standard triple therapy, hydralazine was replaced by felodipine, a new vasodilating dihydropyridine derivative, and the acute effects of the drug on central and renal hemodynamics were monitored. Following baseline measurements, an oral solution of felodipine (0.075-0.1 mg/kg) was given. Fifteen minutes after intake of felodipine, a significant hypotensive response was observed, and the maximal response (23% reduction of mean arterial pressure) occurred after 30 min. There was a linear relationship between the changes in mean arterial pressure and log plasma concentration of felodipine. Cardiac output (dye dilution) increased during maximal blood pressure reduction, from 5.3 +/- 1.0 to 6.6 +/- 2.4 L/min (p less than 0.01), partly because of increased heart rate from 57 +/- 4 to 65 +/- 9.1 beats/min (p less than 0.01) and partly because of increased stroke volume from 93 +/- 14 to 104 +/- 33 ml (p less than 0.05). Renal plasma flow (para-aminohippuric acid clearance) increased significantly (p less than 0.05) from 343 +/- 138 to 391 +/- 154 ml/min, while glomerular filtration rate ([51Cr]EDTA clearance) did not change. Arteriovenous noradrenaline difference increased 36% during felodipine therapy, when corrected for blood flow increase. We conclude that felodipine is a calcium inhibitor with potent vasodilating properties.
No takes yet. Share an insight, caveat, or question.
Andersson et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: